Coincidently, in hematological diseases such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), LAMP2 has also been strongly associated with drug resistance and prognosis. This evidence concerns the gene LAMP2 and acute myeloid leukemia.